Oxidative DNA Damage and the Level of Biothiols, and L-Dopa Therapy in Parkinson’s Disease

QR Code

Oxidative DNA Damage and the Level of Biothiols, and L-Dopa Therapy in Parkinson’s Disease

None

Saved in:

Bibliographic Details
Main Authors:	Jolanta, Dorszewska, Wojciech, Kozubski
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2011
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/21580
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Noradrenergic Mechanisms in Parkinson’s Disease and L-DOPA-Induced Dyskinesia: Hypothesis and Evidences from Behavioural and Biochemical Studies
by: Alachkar, Amal
Published: (2012)

Free Radicals, Oxidative Stress and Oxidative Damage in Parkinson's Disease
by: Repetto, Marisa G., et al.
Published: (2012)

l-Tyrosine and l-DOPA: Promising scaffolds for the synthesis of biologically active compounds
by: Ndayiragije, Euphrem, et al.
Published: (2024-11-01)

Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis
by: Katarzyna Wiszniewska, et al.
Published: (2025-04-01)

Neuroprotective Effects of Herbal Butanol Extracts from Gynostemma pentaphyllum on the Exposure to Chronic Stress in a 6-Hydroxydopamine- Lesioned Rat Model of Parkinson's Disease Treated with or Without L-DOPA
by: Lee, Myung Koo, et al.
Published: (2012)

Food Factors and Oxidative DNA Damage / DNA Repair Systems
by: Hirano, Takeshi, et al.
Published: (2011)

YOD1 regulates oxidative damage of dopamine neurons in Parkinson's disease by deubiquitinating PKM2
by: Xia Zhao, et al.
Published: (2025-07-01)

Associations of genes of DNA repair systems with Parkinson’s disease
by: N. P. Babushkina, et al.
Published: (2022-12-01)

Probing the Mechanism of l‑DOPA 2,3-Dioxygenase Using Synthetic Derivatives of 3,4-Dihydroxyhydrocinnamic Acid
by: Amen Taye Demisew, et al.
Published: (2025-07-01)

Gene Therapy for Parkinson’s Disease
by: Douglas, Michael, et al.
Published: (2011)

Neurometabolic Therapy for Parkinson's Disease
by: N. G. Zhukova, et al.
Published: (2023-07-01)

Impact of Tetrahydropyrido[2,1-b][1,3,5]thiadiazines on L-DOPA Effects in the Tail Suspension Test
by: E. Yu. Bibik, et al.
Published: (2020-06-01)

Tianqi pingchan granule promotes recovery of glymphatic system function in a rat model of l-DOPA-induced dyskinesia
by: Zhihua Liu, et al.
Published: (2025-07-01)

DNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy
by: Urbano, Ana M., et al.
Published: (2011)

Acetyl-L-Carnitine in Parkinson’s Disease
by: Sinicropi, Maria Stefania, et al.
Published: (2012)

Pharmacological methods of therapy in Parkinson’s disease
by: Y. N. Bykov, et al.
Published: (2016-05-01)

Cell Therapy for Parkinson’s Disease: Failure or Success?
by: Guerra-Crespo, Magdalena, et al.
Published: (2011)

Cost and Efficacy of Therapies for Advanced Parkinson's Disease
by: Valldeoriola, Francesc
Published: (2011)

Cell Therapy for Parkinson’s Disease: Status and Perspectives
by: Jensen, Pia, et al.
Published: (2011)

Association of potent inflammatory Cytokine and Oxidative DNA Damage Biomarkers in Stomach cancer patients
by: Akam Jasim Mustafa, et al.
Published: (2022-12-01)

Peripheral monocyte transcriptional signatures of inflammation and oxidative stress in Parkinson’s disease
by: Aaron D. Thome, et al.
Published: (2025-07-01)

The Level of ROS and DNA Damage Mediate with the Type of Cell Death, Senescence or Apoptosis
by: Inoue, Takafumi, et al.
Published: (2012)

Optimization of [18F]-DOPA PET/CT Protocol in Patients with Medullary Thyroid Carcinoma: a Prospective Study
by: N. V. Tsentr, et al.
Published: (2025-03-01)

Physiological plasticity in zebra finch color varieties mitigates DNA damage under oxidative stress
by: Cristiana I. Marques, et al.
Published: (2025-07-01)

Hyponatremia in Parkinson’s Disease: The Impact of Carbidopa-Levodopa Therapy
by: Elizabeth Schumacher, et al.
Published: (2025-06-01)

The Effects of Pilates in Parkinson’s Disease—A Narrative Review
by: Józef Alfons Opara, et al.
Published: (2025-06-01)

Measuring of DNA Damage by Quantitative PCR
by: Mutlu, Ayse Gul
Published: (2012)

Effect of new antitumor compounds based on azoloazine derivatives on the level of DNA damage in normal Vero cells in the DNA comet test
by: A. H. Al-Humairi, et al.
Published: (2024-01-01)

Gene Therapy for Parkinson’s Disease: Towards Non Invasive Approaches
by: Rodríguez, Manuel, et al.
Published: (2011)

Mobile computer technologies in personified therapy of Parkinson’s disease patients
by: Y. N. Bykov, et al.
Published: (2018-02-01)

SiDNA and Other Tools for the Indirect Induction of DNA Damage Responses
by: Quanz, Maria, et al.
Published: (2011)

The study of neurotropic autoantibody levels in patients with epilepsy, Parkinson’s disease and schizophrenia
by: M. V. Baturina, et al.
Published: (2018-02-01)

Human Lymphocytes and Drosophila melanogaster as Model System to Study Oxidative Stress in Parkinson's Disease
by: Jimenez-Del-Rio, Marlene, et al.
Published: (2012)

Decoding Parkinson's Disease: The interplay of cell death pathways, oxidative stress, and therapeutic innovations
by: Tingting Liu, et al.
Published: (2025-09-01)

Recombinant Viral Vectors for Investigating DNA Damage Responses and Gene Therapy of Xeroderma Pigmentosum
by: Quayle, Carolina, et al.
Published: (2011)

DNA DAMAGE AND HOST CELL APOPTOSIS AT THE CONCOMITANT DRUG THERAPY FOR DWARF TAPEWORM INFECTION
by: V. Ya. Bekish, et al.
Published: (2016-05-01)

Pesticides and Parkinson’s Disease
by: Fitzmaurice, Arthur G., et al.
Published: (2011)

Genetics of Parkinson Disease
by: Sassi, Celeste
Published: (2011)

Parkin and Parkinson’s Disease
by: Tay, Shiam-Peng, et al.
Published: (2011)

Pesticides and Parkinson’s Disease
by: Janelle, Drouin-Ouellet, et al.
Published: (2011)